Organizations
Conferences
Info & Opinion
October 7, 2008
In 2008, several ad positions on ClinPage have been sold out. For months. But we’re now able to discuss 2009 ad pricing. Please contact or visit this page, which has a new chart showing our growth this year.
How Arrowhead Electronic Healthcare double-checked 2,698 forms for a global trial using ediaries in 19 languages.
Bulletins about Merck, Microsoft, Zoho, electronic health records, Phoenix Data Systems, information overload, and publication bias.
A few news bulletins on invivodata, M. D. Anderson, Instem, Eli Lilly, TheraSim and Kendle
A few news bulletins on Encorium Group, SRI International, Integrated Clinical Trial Services, Datafarm, Pioneer Behavioral Health, Frost & Sullivan and Oracle
Chuck Piccirillo discusses the company’s strengths and current direction.
Bulletins on Acorn, Parexel, ACM-Pivotal, Xentech, Southern Research Institute and CBI
DecisionView, a computationally intensive patient recruitment simulation firm, won an award from research firm IDC and PPM Media, a relatively unknown entrant in the pharmaceutical meeting space. Here’s a previous ClinPage story on the firm. For $62 million, Lilly settled litigation with 32 states that alleged the company promoted the… more...
The National Cancer Institute selected Akaza Research as a licensed provider of support in two areas of its caBIG technology infrastructure effort: deployment and documentation and training materials. Said Cal Collins, Akaza’s CEO: “We will be able to leverage our experience and infrastructure we have developed for supporting our OpenClinica… more...
Industry legend Paul Bleicher will soon step down from daily responsibilities at Phase Forward. The Boston-area electronic data capture company Bleicher co-founded in 1997 pioneered software and services for the largest sponsor companies in the industry, forging long-term deals with Lilly and GSK that attracted other customers. Phase Forward today… more...
Paradigm Spine selected the PharmaPros automated trial management solution, Dataflow Manager. The software tracks the status of a trial, including any available information, including lab data, case report forms, images, and randomization. “After careful evaluation of our internal needs and capacity, along with a thorough analysis of available external options,… more...
Yesterday, Pfizer announced that it was abandoning new projects in cardiovascular disease. This was about as expected as Federal Express investing in horse-based shipping routes. Then GSK leaked word it was cutting 850 jobs, or 6 percent of its R&D headcount, in the wake of an arrival of a new… more...
The FDA will spend $2.5 billion on better computers over the next ten years. The agency selected large, well-connected IT giants that generally have no specialized biomedical or clinical-trial-specific research systems. “This contract sets the stage for the FDA to have IT to acquire, analyze and act on data critical… more...
The FDA said an analysis of 41 trials suggests the statin class poses no risk of Lou Gehrig’s disease. There are anecdotal reports of other central nervous complications with the statin class that remain unresolved. Here’s the agency’s statement. Bio-Imaging Technologies appointed Peter Benton as president of its electronic data… more...